The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of genomic biomarkers on a validated clinical risk prediction model for upgrading/upstaging among men with low-risk prostate cancer.
 
Avery Braun
No Relationships to Disclose
 
Janet E. Cowan
No Relationships to Disclose
 
June M. Chan
Employment - Adela (I); GRAIL (I); Myriad Genetics (I)
Stock and Other Ownership Interests - GRAIL (I)
Research Funding - Adela (I); GenomeDx (Inst); Genomic Health (Inst); GRAIL (I); Myriad Genetics (Inst)
Travel, Accommodations, Expenses - GRAIL (I); Myriad Genetics (I)
 
John Neuhaus
No Relationships to Disclose
 
Peter Carroll
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; Nutcracker Therapeutics, Inc.
Honoraria - BIOPHARM; Exact Sciences
Consulting or Advisory Role - Alessa Therapeutics; Francis Medical; Insightec; Nutcracker Therapeutics, Inc.; Progenics
Research Funding - Intuitive Surgical (Inst)
 
Matthew R. Cooperberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; ConcertAI; Dendreon; Exact Sciences; Merck; Pfizer; Veracyte; Verana Health